Combination of resveratrol and piperine to target doxorubicin resistance in breast cancer: An in vitro and in vivo study


	The sensitivity of EMT-6/P and EMT-6/DOX cell lines to DOX at various doses was evaluated using the anti-proliferative assay (MTT).

Part of: AlHur MJ, Barakova N, Talib WH (2024) Combination of resveratrol and piperine to target doxorubicin resistance in breast cancer: An in vitro and in vivo study. Pharmacia 71: 1-10. https://doi.org/10.3897/pharmacia.71.e122171